Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: New Pacer--OPPOSITION OF PLAINTIFFS HTC CORPORATION AND HTC AMERICA, INC. TO DEF




Let me ask you this: did the EDOT Markman ruling pertain anyway to the validity of the patents?I didn't notice any mention of validity in Judge Wards ruling

If not then I guess the interpretations given would be for infringement. I realize that the jury ultimately determines infringement..

If you follow the trail back to the message I was responding to the point was made by another that the non-final rejection of the PTO on claims 1- 10 of the 336 he didn't see where Judge Ward ruled that way and why the difference. I merely pointed out that the Judge's Markman ruling was concerning infringement issues, not validity. Is that correct in your opinion?

Share
New Message
Please login to post a reply